It can be confirmed by decreased concentrations of apoA-I and HDL resulting in decreased PON1(P) activity in the blood of AP patients compared to healthy subjects in both individuals with the CC and TC genotype for SNP rs5069 in the APOA1 gene. The gene discussed is PON1; the disease is alkaline phosphatase measurement.